Overview Financials News + Filings Key Docs Ownership Insiders
|
|
bioAffinity Technologies, Inc.
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 |
| | 10-K | 10-K | S-1/A |
| Revenues | 100.0% | | 100.0% |
| Cost of goods sold | 9.7% | | 184.0% |
| Gross profit | 90.3% | | -84.0% |
| Selling, general and administrative | 56778.5% | | |
| Research and development | 23793.0% | | |
| General and administrative | | | 70.3% |
| EBITDA | -83299.5% | | -184.0% |
| Depreciation | 212.0% | | |
| EBIT | -83511.5% | | -184.0% |
| Pre-tax income | -169720.0% | | -513.4% |
| Income taxes | 51.2% | | 0.2% |
| Net income | -169771.2% | | -513.6% |
|